CMET-16. A PHASE II TRIAL OF BEVACIZUMAB IN PATIENTS WITH RECURRENT SOLID TUMOR BRAIN METASTASES WHO HAVE PROGRESSED FOLLOWING WHOLE BRAIN RADIATION THERAPY (WBRT): FINAL RESULTS

BACKGROUND: Brain metastases (BM) are the most common intracranial tumor with limited treatment options following the progression after WBRT. METHODS: This open label phase 2 study for patients have progressed following WBRT enrolled participants who received bevacizumab 10 mg/kg intravenously every...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Kumthekar, Priya, Dixit, Karan, Grimm, Sean, Lukas, Rimas, Schwartz, Margaret, Helenowski, Irene, Sharp, Laura, Nelson, Valerie, Raizer, Jeffrey
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2019
Soggetti:
CNS Metastasis
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847740/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.217
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi